SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 461.80
arrow_downward
-0.86%(-4.00) 1D
Jul 17, 5:29:30 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 451.80
High
SEK 461.80
Low
SEK 442.40
Mkt. cap
165.05B
Avg. vol.
452.32K
Volume
0.00
P/E ratio
123.34
52-wk high
SEK 487.00
52-wk low
SEK 261.20
EPS
SEK 3.74
Shares outstanding
357.41M
No. of employees
2K
Open
SEK 451.80
High
SEK 461.80
Low
SEK 442.40
Mkt. cap
165.05B
Avg. vol.
452.32K
Volume
0.00
P/E ratio
123.34
52-wk high
SEK 487.00
52-wk low
SEK 261.20
EPS
SEK 3.74
Shares outstanding
357.41M
No. of employees
2K
News stories
From sources across the web
Simply Wall Street
·
1 day ago
Swedish Orphan Biovitrum (OM:SOBI) Stock Faces Margin Compression As One Off Loss Clouds EPS
TradingView
·
2 days ago
SOBI: Q2 revenue rose 29% with a 35% EBITA margin; 2026 outlook upgraded on broad-based growth
Investing.com Canada
·
2 days ago
Earnings call transcript: Sobi lifts 2026 outlook after strong Q2 sales growth
TipRanks
·
2 days ago
Sobi lifts 2026 outlook as Q2 revenue surges and gout pipeline advances
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA. Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world.
In 2025 it had a revenue of SEK 28.2 billion and aorund 1,900 employees. Wikipedia
About Swedish Orphan Biovitrum AB (publ)
AI content may include mistakes. Learn more